Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2001 2
2002 1
2003 5
2004 8
2005 3
2006 5
2007 7
2008 6
2009 7
2010 4
2011 8
2012 6
2013 5
2014 1
2015 8
2016 7
2017 12
2018 8
2019 5
2020 6
2021 15
2022 9
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.
Saliba RM, Alousi AM, Pidala J, Arora M, Spellman SR, Hemmer MT, Wang T, Abboud C, Ahmed S, Antin JH, Beitinjaneh A, Buchbinder D, Byrne M, Cahn JY, Choe H, Hanna R, Hematti P, Kamble RT, Kitko CL, Laughlin M, Lekakis L, MacMillan ML, Martino R, Mehta PA, Nishihori T, Patel SS, Perales MA, Rangarajan HG, Ringdén O, Rosenthal J, Savani BN, Schultz KR, Seo S, Teshima T, van der Poel M, Verdonck LF, Weisdorf D, Wirk B, Yared JA, Schriber J, Champlin RE, Ciurea SO. Saliba RM, et al. Transplant Cell Ther. 2022 Oct;28(10):681-693. doi: 10.1016/j.jtct.2022.07.013. Epub 2022 Jul 16. Transplant Cell Ther. 2022. PMID: 35853610 Free PMC article.
Azacitidine Post-transplant Maintenance Improves Disease Progression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Pasvolsky O, Saliba RM, Popat UR, Alousi A, Mehta R, Yeh J, Al-Atrash G, Adeel M, Ramdial J, Marin D, Rondon G, Kebriaei P, Champlin R, Daver N, Dinardo C, Short NJ, Shpall EJ, Oran B. Pasvolsky O, et al. Among authors: saliba rm. Clin Lymphoma Myeloma Leuk. 2024 May;24(5):e196-e204. doi: 10.1016/j.clml.2024.01.012. Epub 2024 Feb 3. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38403505
Hematopoietic cell transplantation can be safely performed after COVID-19.
Marinos A, Ramdial J, Khawaja F, Saliba RM, Shigle TL, Alousi AM, Rondon G, Chen J, Ledesma C, Champlin RE, Daher M, Chen G, Marin D, Rezvani K, Shpall EJ, Chemaly RF. Marinos A, et al. Among authors: saliba rm. Bone Marrow Transplant. 2023 Dec;58(12):1410-1412. doi: 10.1038/s41409-023-02105-1. Epub 2023 Sep 19. Bone Marrow Transplant. 2023. PMID: 37726490 No abstract available.
HLA Factors versus Non-HLA Factors for Haploidentical Donor Selection.
Mehta RS, Cao K, Saliba RM, Al-Atrash G, Alousi AM, Lontos K, Marcoux C, Carmazzi Y, Rondon G, Bashir Q, Hosing CM, Kebriaei P, Khouri I, Marin D, Nieto Y, Oran B, Popat UR, Qazilbash MH, Ramdial J, Rezvani K, Champlin RE, Shpall EJ. Mehta RS, et al. Among authors: saliba rm. Transplant Cell Ther. 2023 Mar;29(3):189-198. doi: 10.1016/j.jtct.2022.11.027. Epub 2022 Dec 5. Transplant Cell Ther. 2023. PMID: 36470579 Free PMC article.
Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft-Versus-Host Disease.
Mehta RS, Saliba RM, Jan A, Shigle TL, Wang E, Nieto Y, Ciurea SO, Oran B, Im J, Olson A, Marin D, Qazilbash M, Khouri I, Rondon G, Anderlini P, Rezvani K, Popat U, Kebriaei P, Shpall E, Champlin R, Alousi A. Mehta RS, et al. Among authors: saliba rm. Transplant Cell Ther. 2021 Mar;27(3):272.e1-272.e5. doi: 10.1016/j.jtct.2020.12.011. Epub 2020 Dec 16. Transplant Cell Ther. 2021. PMID: 33781539 Free article.
Steroid-Refractory Acute GVHD: Predictors and Outcomes.
Westin JR, Saliba RM, De Lima M, Alousi A, Hosing C, Qazilbash MH, Khouri IF, Shpall EJ, Anderlini P, Rondon G, Andersson BS, Champlin R, Couriel DR. Westin JR, et al. Among authors: saliba rm. Adv Hematol. 2011;2011:601953. doi: 10.1155/2011/601953. Epub 2011 Nov 3. Adv Hematol. 2011. PMID: 22110505 Free PMC article.
Impact of graft composition on outcomes of haploidentical bone marrow stem cell transplantation.
Saliba RM, Veltri L, Rondon G, Chen J, Al-Atrash G, Alousi A, Martinez C, Augustine L, Hosing CM, Oran B, Rezvani K, Shpall EJ, Kebriaei P, Khouri IF, Popat U, Champlin RE, Ciurea SO. Saliba RM, et al. Haematologica. 2021 Jan 1;106(1):269-274. doi: 10.3324/haematol.2019.227371. Haematologica. 2021. PMID: 32107328 Free PMC article. No abstract available.
Post-Transplantation Cyclophosphamide Versus Tacrolimus and Methotrexate Graft-Versus-Host Disease Prophylaxis for HLA-Matched Donor Transplantation.
Mehta RS, Saliba RM, Rondon G, Al-Atrash G, Bashir Q, Hosing CM, Kebriaei P, Khouri I, Nieto Y, Oran B, Popat UR, Qazilbash MH, Ramdial J, Srour SA, Champlin RE, Rezvani K, Shpall EJ, Alousi AM. Mehta RS, et al. Among authors: saliba rm. Transplant Cell Ther. 2022 Oct;28(10):695.e1-695.e10. doi: 10.1016/j.jtct.2022.07.021. Epub 2022 Jul 25. Transplant Cell Ther. 2022. PMID: 35902049 Free article.
128 results